NASDAQ:IBB

iShares Biotechnology ETF (IBB) Price, Holdings, & News

$128.57

+0.40 (+0.31%)

(As of 08/11/2023 08:48 PM ET)

Compare

Today's Range: $127.63
▼
$128.81
50-Day Range: $124.38
▼
$131.81
52-Week Range: $113.37
▼
$138.74

Volume: 725,500 shs
Average Volume: 1.56 million shs
Market Capitalization: $7.49 billion

Assets Under Management: $7.46 billion
Dividend Yield: 0.26%
Net Expense Ratio: 0.44%

About iShares Biotechnology ETF (NASDAQ:IBB)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

IBB Price History

30 days | 90 days | 365 days | Advanced Chart

IBB ETF News Headlines

July 6, 2023 | finance.yahoo.com

IBB - iShares Biotechnology ETF

July 4, 2023 | baystreet.ca

Why I’m Buying This Biotech ETF Today

August 14, 2023 | Behind the Markets (Ad)

Laser breakthrough could send stock soaring 2,467%

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

June 21, 2023 | barrons.com

15 Biotech Stocks Wall Street Analysts Say Are Too Cheap

June 15, 2023 | seekingalpha.com

Biotech Continues To Struggle Against The Broad Market, IBB Remains A Hold

June 8, 2023 | msn.com

iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.0062

May 31, 2023 | msn.com

Unusual Put Option Trade in BlackRock Institutional Trust Company N.A. - iShares Biotechnology ETF (IBB) Worth $94.70K

May 11, 2023 | forbes.com

Best Biotech Stocks

August 14, 2023 | Behind the Markets (Ad)

The single greatest medical breakthrough of all time?

We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.

May 10, 2023 | finance.yahoo.com

Biotech ETFs Pop on M&A Resurgence

See More Headlines

Receive IBB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: iShares
Fund Name: iShares Biotechnology ETF
Tax Classification: Regulated Investment Company
Stock Exchange: NASDAQ
Current Symbol: NASDAQ:IBB
Inception Date: 2/5/2001
Fund Manager: Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Web: N/A
Phone: N/A

Fund Focus

Asset Class: Equity
Benchmark: ICE Biotechnology Index (TR) (USD)
Category: Sector
Focus: Health Care
Development Level: Developed Markets
Region: North America
Number of Holdings: 270

Fund Statistics

Assets Under Management: $7.46 billion
Average Daily Volume: $1.49 million
Discount/Premium: 8.03%

Administrator, Advisor and Custodian

Administrator: JPMorgan Chase Bank, N.A.
Advisor: BlackRock Fund Advisors
Custodian: JPMorgan Chase Bank, N.A.
Distributor: BlackRock Investments, LLC
Transfer Agent: JPMorgan Chase Bank, N.A.
Trustee: N/A
Lead Market Maker: Latour Trading

Options

Optionable: Optionable
Options Volume: 576
Put Options: 242
Call Options: 334
Short Interest: 9,990,000 shs

Miscellaneous

Outstanding Shares: 58,250,000
Beta: 0.81
Creation Unit: 50,000
Creation Fee: $614.00

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

iShares Biotechnology ETF Expenses

Type	IBB	Health Care ETFs	Equity ETFs	NASDAQ ETFs	All ETFs
Management Fee	0.44%	0.57%	0.52%	0.46%	0.50%
Other Expenses	0.00%	0.40%	0.53%	0.29%	0.58%
Total Expense	0.44%	0.72%	0.69%	0.55%	0.69%
Fee Waiver	0.00%	-0.50%	-0.56%	-0.23%	-0.60%
Net Expense	0.44%	0.61%	0.59%	0.51%	0.57%

iShares Biotechnology ETF (IBB) Holdings & Exposure

Top 10 IBB Holdings

IBB Sector Exposure

IBB Industry Exposure

Full Holdings Details

Key Executives

George G. C. Parker Ph.D.
Independent Chairman of the Board of Trustees

Michael Arthur Latham
President, Trustee

Jack Gee
Chief Financial Officer, Treasurer

Geoffrey D. Flynn
Chief Operating Officer, Executive Vice President

Bio & Compensation -

Amy Schioldager
Executive Vice President

Ira P. Shapiro
Vice President, Chief Legal Officer

Matt Tucker
Vice President

Bio & Compensation -

Eilleen M. Clavere
Secretary

Cecilia H. Herbert
Independent Trustee

Charles A. Hurty
Independent Trustee

Similar ETFs

Institutional Ownership

View All Institutional Transactions

IBB ETF - Frequently Asked Questions

How have IBB shares performed in 2023?: iShares Biotechnology ETF's stock was trading at $131.29 on January 1st, 2023. Since then, IBB shares have decreased by 2.1% and is now trading at $128.57.
View the best growth stocks for 2023 here.
How often does iShares Biotechnology ETF pay dividends? What is the dividend yield for iShares Biotechnology ETF?: iShares Biotechnology ETF declared a quarterly dividend on Tuesday, June 6th. Shareholders of record on Thursday, June 8th will be paid a dividend of $0.0062 per share on Tuesday, June 13th. This represents a $0.02 dividend on an annualized basis and a dividend yield of 0.02%. The ex-dividend date is Wednesday, June 7th.
Read our dividend analysis for IBB.
What does IBB invest in?: iShares Biotechnology ETF is a equity fund issued by iShares. IBB focuses on health care investments and follows the ICE Biotechnology Index (TR) (USD). The fund's investments total to approximately $7.46 billion assets under management.
What stocks does iShares Biotechnology ETF hold?: IBB invests in 270 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), IQVIA (IQV), Biogen (BIIB), Seagen (SGEN), Moderna (MRNA), Illumina (ILMN) and Mettler-Toledo International (MTD).
What is the management fee for iShares Biotechnology ETF?: iShares Biotechnology ETF's management fee is 0.44% and has no other recorded expenses or fee waivers. The net expense ratio for IBB is 0.44%.
When did iShares Biotechnology ETF's stock split?: Shares of iShares Biotechnology ETF split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly created shares were issued to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

What other stocks do shareholders of iShares Biotechnology ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL).
What is iShares Biotechnology ETF's stock symbol?: iShares Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."
Who are iShares Biotechnology ETF's major shareholders?: iShares Biotechnology ETF's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Bank Julius Baer & Co. Ltd Zurich (485.07%), Citigroup Inc. (4.04%), JPMorgan Chase & Co. (3.49%), Commerce Bank (1.23%), Healthcare of Ontario Pension Plan Trust Fund (1.20%) and LPL Financial LLC (0.92%).
How do I buy shares of iShares Biotechnology ETF?: Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is iShares Biotechnology ETF's stock price today?: One share of IBB stock can currently be purchased for approximately $128.57.
How much money does iShares Biotechnology ETF make?: iShares Biotechnology ETF (NASDAQ:IBB) has a market capitalization of $7.49 billion.

This page (NASDAQ:IBB) was last updated on 8/14/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial